N. Fujiki

The Influence of Tofogliflozin on Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus

I. Shimomura, H. Kaneto, T. Matsuoka, 2021, Diabetes Therapy.

Association of glycated albumin to HbA1c ratio with diabetic retinopathy but not diabetic nephropathy in patients with type 2 diabetes.

Y. Umayahara, M. Koga, M. Hatazaki, 2017, Clinical biochemistry.

Basal Insulin Requirement Is ∼30% of the Total Daily Insulin Dose in Type 1 Diabetic Patients Who Use the Insulin Pump

I. Shimomura, H. Kaneto, T. Matsuoka, 2011, Diabetes Care.

Is central obesity a good predictor of carotid atherosclerosis in Japanese type 2 diabetes with metabolic syndrome?

H. Kaneto, M. Matsuhisa, Y. Yamasaki, 2007, Endocrine journal.

Tofogliflozin long-term effects on atherosclerosis progression and major clinical parameters in patients with type 2 diabetes mellitus lacking a history of cardiovascular disease: a 2-year extension study of the UTOPIA trial

I. Shimomura, H. Kaneto, T. Matsuoka, 2023, Cardiovascular Diabetology.